Normal view MARC view ISBD view

Urokinase-type plasminogen activator system in breast cancer: association with tamoxifen therapy in recurrent disease.

Meijer-van Gelder, Marion E

Urokinase-type plasminogen activator system in breast cancer: association with tamoxifen therapy in recurrent disease. [electronic resource] - Cancer research Jul 2004 - 4563-8 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

ISSN: 0008-5472

Standard No.: 10.1158/0008-5472.CAN-03-3848 doi

Subjects--Topical Terms:
Adult
Aged
Aged, 80 and over
Breast Neoplasms--drug therapy
Female
Humans
Middle Aged
Multivariate Analysis
Neoplasm Recurrence, Local--drug therapy
Plasminogen Activator Inhibitor 1--metabolism
Plasminogen Activator Inhibitor 2--metabolism
Proportional Hazards Models
Receptors, Cell Surface--metabolism
Receptors, Estrogen--biosynthesis
Receptors, Urokinase Plasminogen Activator
Retrospective Studies
Tamoxifen--therapeutic use
Urokinase-Type Plasminogen Activator--metabolism